Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Barella
Observed names:
Barella Marco,
M. Barella,
Marco BARELLA
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
MultiMedica,
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0001-8559-9101
Observed ORCID:
0000-0001-8559-9101
OpenAlex ID:
A5035721133
Morphologic and molecular classification of lung neuroendocrine neoplasms
2021
·
Jasna Metovic
, Marco Barella
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
86
PDF
A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors
2021
·
Giuseppe Pelosi
, Fabrizio Bianchi
, et al.
·
Endocrine Pathology
·
26
Recent advances and current controversies in lung neuroendocrine neoplasms✰
2021
·
Jasna Metovic
, Fabrizio Bianchi
, et al.
·
Seminars in Diagnostic Pathology
·
15
Neuroendocrine neoplasms of the lung: a pathology update
2021
·
Jasna Metovic
, Marco Barella
, et al.
·
memo - Magazine of European Medical Oncology
·
10
PDF
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the “S1STeM 371” Trial
2025
·
Sebastiano Nazzani
, Adele Busico
, et al.
·
European Journal of Cancer
·
7
SMARCA2 Deficiency While Preserving SMARCA4 and SMARCB1 in Lung Neuroendocrine Carcinomas
2021
·
Jasna Metovic
, Fabrizio Bianchi
, et al.
·
Journal of Thoracic Oncology
·
7
PDF
Clinical implications of lung neuroendocrine neoplasm classification
2020
·
Jasna Metovic
, Marco Barella
, et al.
·
Expert Review of Anticancer Therapy
·
5
Sex Cord Stromal Tumors of the Testis
2024
·
Maurizio Colecchia
, Michelangelo Fiorentino
, et al.
·
Surgical pathology clinics
·
4
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report
2018
·
Alessandro Del Gobbo
, Nicola Fusco
, et al.
·
Cellular Oncology
·
3
Pathological Complete Response in Metastatic Renal Cell Carcinoma Patients Treated With Cabozantinib Plus Nivolumab. Case Series and Literature Review
2025
·
Marco Stellato
, Simone Rota
, et al.
·
Clinical Genitourinary Cancer
·
2
Lynch syndrome–associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort
2026
·
A. Rametta
, M. Barella
, et al.
·
Familial Cancer
·
1
PDF
Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey
2026
·
Giuseppe Nicolò Fanelli
, Anna Caliò
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
1
PDF
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib
2025
·
Amedeo Nuzzo
, Marco Barella
, et al.
·
JCO Precision Oncology
·
1
Cutaneous tricholemmal carcinoma: a 15-year single center experience
2021
·
Francesca L. BOGGIO
, Elena GUANZIROLI
, et al.
·
Italian Journal of Dermatology and Venereology
·
1
PDF
Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
2021
·
Carlo Pescia
, Francesca Boggio
, et al.
·
Journal of Clinical Medicine
·
1
PDF
CD34-Positive Blast Count and p53 Expression in Bone Marrow Biopsies of Patients with Low-Risk Myelodysplastic Syndromes: Potential Predictive Tools of Response to Erythropoietin Stimulating Agents
2021
·
Francesca Boggio
, Alessandro Del Gobbo
, et al.
·
Pathobiology
·
1
Early stage lung cancer: pathologist’s perspective
2020
·
Francesca Boggio
, Alessandro Del Gobbo
, et al.
·
Journal of Thoracic Disease
·
1
PDF
GLOBO H targeting CAR T Cells: generation and preclinical activity in gastrointestinal cancer cell lines
2026
·
Francesca Putti
, Marco Gentili
, et al.
·
Journal of Experimental & Clinical Cancer Research
A sixteen-genus lung bacterial profile is associated with early-stage non-small cell lung cancer progression
2026
·
Chiara M. Ciniselli
, Armando G. Licata
, et al.
·
Journal of Translational Medicine
Rarity within rarity: complete response to chemoimmunotherapy in a patient with polymerase epsilon (POLE)-mutated locally advanced jejunal carcinoma
2026
·
Michele Prisciandaro
, Federica Morano
, et al.
·
The Oncologist
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors management
2026
·
Sebastiano Nazzani
, Carlo Silvani
, et al.
·
British Journal of Cancer
Multiomics approach for patient stratification and novel target identification in metastatic clear cell renal carcinoma (MeetUro 31): Preliminary analysis of radiomics features—A Meet-URO and AIRC study (NCT05782400).
2026
·
Giuseppe Procopio
, Marco Stellato
, et al.
·
Journal of Clinical Oncology
PDF
710 Do Tumor Deposits Demand More? A Multicenter Validation Of Sassun–Mayo Stages In N1 Colon Cancer Assessing Different Chemotherapy Regimens
2026
·
Giovanna Sabella
, Chiara Rossi
, et al.
·
Laboratory Investigation
775 Tumor and Immune Dynamics in BCG-Treated Non-Muscle Invasive Bladder Cancer: an Explorative Study
2026
·
Marco Barella
, Huber Veronica
, et al.
·
Laboratory Investigation
1603 Microbiome β-Diversity and Immunosoppresive FOXP3+ Cells: Two Rising Stars on the Scene of Non-Small Cell Lung Cancers
2026
·
Marco Barella
, Giancarla Bernardo
, et al.
·
Laboratory Investigation
PDF
Show more works
View as search
Works count:
36
Citation count:
172
H-index:
6
I10-index:
4
Year
Topic
Type